This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Hologic (HOLX) Could Beat Earnings Estimates Again
by Zacks Equity Research
Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
What Makes Hologic (HOLX) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Hologic (HOLX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks.com featured highlights Jabil, PepsiCo, DICK'S Sporting Goods, Hologic and Suzano
by Zacks Equity Research
Jabil, PepsiCo, DICK'S Sporting Goods, Hologic and Suzano have been highlighted in this Screen of The Week article.
5 Stocks With High ROE to Buy as Rate Hike Fears Subside
by Supriyo Bose
Jabil (JBL), PepsiCo (PEP), DICK'S Sporting (DKS), Hologic (HOLX) and Suzano (SUZ) are some of the stocks with high ROE to profit from as rate hike fears subside.
Hologic, Inc. (HOLX) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Hologic (HOLX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
HOLX or EW: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HOLX vs. EW: Which Stock Is the Better Value Option?
Hologic (HOLX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Hologic (HOLX) closed at $75.55, marking a +0.99% move from the previous day.
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Here's Why You Should Retain Hologic (HOLX) Stock for Now
by Zacks Equity Research
Investors are optimistic about Hologic (HOLX), led by the continued strength of the GYN Surgical business.
Hologic (HOLX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Hologic (HOLX) closed at $75.75, marking a +0.32% move from the previous day.
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Hologic (HOLX) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Hologic (HOLX) closed at $74.10 in the latest trading session, marking a +1.08% move from the prior day.
Hologic (HOLX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Hologic (HOLX) closed at $75.89, marking a +0.15% move from the previous day.
Hologic's (HOLX) Panther Utilization Rises, Supply Issue Ails
by Zacks Equity Research
Hologic (HOLX) registers procedural volumes return in GYN Surgical as well as acceleration from its new business lines.
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Hologic (HOLX) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Hologic (HOLX) closed the most recent trading day at $74.80, moving +1.36% from the previous trading session.
Here's Why You Should Retain Hologic (HOLX) Stock For Now
by Zacks Equity Research
Investors continue to be optimistic about Hologic (HOLX) on the back of its continued strength in the Breast Health arm.
Is Trending Stock Hologic, Inc. (HOLX) a Buy Now?
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Hologic (HOLX) Q4 Earnings Beat Estimates, Margins Down
by Zacks Equity Research
Lower sales of COVID-19 assays and supply chain challenges drag Hologic's (HOLX) top line down.
Hologic (HOLX) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Hologic (HOLX) delivered earnings and revenue surprises of 32.26% and 9.98%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Hologic (HOLX) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Hologic (HOLX) closed at $63.60, marking a +1.74% move from the previous day.
Non-COVID Diagnostics Sales to Aid Hologic (HOLX) Q4 Earnings
by Zacks Equity Research
Hologic's (HOLX) Molecular Diagnostics sales are likely to have been affected by the significant drop in demand for COVID-19 testing.
Hologic (HOLX) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Hologic's (HOLX) interventional business is likely to have faced continued supply chain headwinds related to disposable biopsy needles, hampering its performance.